SE418616B - Forfarande for framstellning av delta?723-cefalosporinforeningar fran 7-skyddade amino-delta?722-cefalosporinestrar - Google Patents

Forfarande for framstellning av delta?723-cefalosporinforeningar fran 7-skyddade amino-delta?722-cefalosporinestrar

Info

Publication number
SE418616B
SE418616B SE7512818A SE7512818A SE418616B SE 418616 B SE418616 B SE 418616B SE 7512818 A SE7512818 A SE 7512818A SE 7512818 A SE7512818 A SE 7512818A SE 418616 B SE418616 B SE 418616B
Authority
SE
Sweden
Prior art keywords
delta
cephalosporine
esters
procedure
preparation
Prior art date
Application number
SE7512818A
Other languages
English (en)
Other versions
SE7512818L (sv
Inventor
J A Webber
Heyningen E M Van
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7512818L publication Critical patent/SE7512818L/sv
Publication of SE418616B publication Critical patent/SE418616B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
SE7512818A 1968-02-07 1975-11-14 Forfarande for framstellning av delta?723-cefalosporinforeningar fran 7-skyddade amino-delta?722-cefalosporinestrar SE418616B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70352368A 1968-02-07 1968-02-07
US79088669A 1969-01-13 1969-01-13
US79084269A 1969-01-13 1969-01-13

Publications (2)

Publication Number Publication Date
SE7512818L SE7512818L (sv) 1975-11-14
SE418616B true SE418616B (sv) 1981-06-15

Family

ID=27418758

Family Applications (3)

Application Number Title Priority Date Filing Date
SE6901500A SE384511B (sv) 1968-02-07 1969-02-05 7-skyddad amino-delta?722?71-cefalosporansyraester, for anvendning som mellanforening vid framstellning av delta?723?71-cefalosporinantibiotika
SE7200411A SE407064B (sv) 1968-02-07 1972-01-14 I 7-stellnig skyddad 3-bromometyl-deltaÿ2-cefalosporansyraester till anvendning som mellanforening vid franstellning av antibiotiskt aktiva deltaÿ3-cefalosporansyraderivat
SE7512818A SE418616B (sv) 1968-02-07 1975-11-14 Forfarande for framstellning av delta?723-cefalosporinforeningar fran 7-skyddade amino-delta?722-cefalosporinestrar

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE6901500A SE384511B (sv) 1968-02-07 1969-02-05 7-skyddad amino-delta?722?71-cefalosporansyraester, for anvendning som mellanforening vid framstellning av delta?723?71-cefalosporinantibiotika
SE7200411A SE407064B (sv) 1968-02-07 1972-01-14 I 7-stellnig skyddad 3-bromometyl-deltaÿ2-cefalosporansyraester till anvendning som mellanforening vid franstellning av antibiotiskt aktiva deltaÿ3-cefalosporansyraderivat

Country Status (11)

Country Link
JP (3) JPS524558B1 (sv)
BE (1) BE728053A (sv)
CH (1) CH534694A (sv)
DK (1) DK140726B (sv)
FI (1) FI56535C (sv)
FR (3) FR2001491B1 (sv)
GB (2) GB1265333A (sv)
IL (2) IL40447A (sv)
LU (1) LU57932A1 (sv)
NL (1) NL173407C (sv)
SE (3) SE384511B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1360860A (en) * 1970-07-08 1974-07-24 Ciba Geigy Ag Cepham compounds process for their manufacture and compositions containing them
JPS53164082U (sv) * 1977-05-31 1978-12-22
JPS5899787U (ja) * 1981-12-28 1983-07-07 奥野電器株式会社 ランプ用ソケツト
EP0300546B1 (en) * 1987-07-10 1995-08-09 Gist-Brocades N.V. Process for the preparation of cephem compounds and cephalosporin derivatives

Also Published As

Publication number Publication date
IL40447A (en) 1976-02-29
IL41553A (en) 1976-02-29
SE407064B (sv) 1979-03-12
SE7512818L (sv) 1975-11-14
NL6902013A (sv) 1969-08-11
JPS524559B1 (sv) 1977-02-04
FR2085656A1 (sv) 1971-12-31
JPS524558B1 (sv) 1977-02-04
FR2001491B1 (sv) 1973-07-13
BE728053A (sv) 1969-08-07
DK140726B (da) 1979-11-05
CH534694A (de) 1973-03-15
GB1265332A (sv) 1972-03-01
DK140726C (sv) 1980-03-31
SE384511B (sv) 1976-05-10
FI56535C (fi) 1980-02-11
JPS4924076B1 (sv) 1974-06-20
NL173407C (nl) 1984-01-16
FR2095486A5 (sv) 1972-02-11
LU57932A1 (sv) 1969-09-17
FR2001491A1 (sv) 1969-09-26
NL173407B (nl) 1983-08-16
FR2085656B1 (sv) 1974-08-23
FI56535B (fi) 1979-10-31
GB1265333A (sv) 1972-03-01

Similar Documents

Publication Publication Date Title
SE408367B (sv) Forfarande for framstellning av cigarrettfilter
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
SE401087B (sv) Forfarande for framstellning av ett antibakteriellt preparat innehallande penicillinderivat
DK158519C (da) Benzylpenicillinderivat til anvendelse som udgangsmateriale ved fremgangsmaaden til fremstilling af alfa-aminopenicillinestere
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
NO138280C (no) Fremgangsmaate for fremstilling av roerformede gjenstander
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE417969B (sv) Forfarande for framstellning av 3-metylencefalosporinforeningar
SE385692B (sv) Forfarande for framstellning av aminoalkoholer herrorande fran orto-transhydroxi-kanolsyror
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE418616B (sv) Forfarande for framstellning av delta?723-cefalosporinforeningar fran 7-skyddade amino-delta?722-cefalosporinestrar
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE402288B (sv) Forfarande for framstellning av foreningar vilka er antagonister mot vissa verkningar av histamin
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE402006B (sv) Forfarande for framstellning av eteniskt omettade karbonylforeningar utgaende fran eteniskt omettade tertiera alkoholer
SE390635B (sv) Forfarande for framstellning av tiazolinforeningar
SE380796B (sv) Forfarande for framstellning av cyklopentanderivat
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE398232B (sv) Forfarande for framstellning av bensodiazepinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7512818-1

Effective date: 19890911

Format of ref document f/p: F